Evidence map›Paper›PMID 30120210›Full record

ReviewCancer research2018

Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How.

Jeannine M Salamone, Wanda Lucas, Shelley B Brundage, Jamie N Holloway, Sherri M Stahl, Nora E Carbine, Margery London, Naomi Greenwood, Rosa Goyes, Deborah Charles Chisholm and 6 more

Abstract readReview
In one paragraph

Review in Cancer research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Engaging Patient Advocates to Reduce Breast Cancer Disparities: Opportunities to Advance Breast Cancer Research and Engagement.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  3. Patient Advocate-Trainee Engagement in Oncology Education: Insights from a Short Pilot Survey.Journal of cancer education : the official journal of the American Association for Cancer Education · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jeannine M SalamoneGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Wanda LucasGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Shelley B BrundageGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Jamie N HollowayGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Sherri M StahlGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Nora E CarbineGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Margery LondonGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Naomi GreenwoodGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Rosa GoyesGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Deborah Charles ChisholmGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Erin PriceGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Roberta CarlinGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Susan WinarskyGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Kirsten B BakerGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Julia MauesGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C.
Ayesha N Shajahan-HaqGeorgetown Breast Cancer Advocates, Department of Oncology, Breast Cancer Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. ans33@georgetown.edu.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
Optimizing Targeted Breast Cancer Therapy by Mathematical Modeling and Experimental StudiesR01CA201092 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI BAUMANN, WILLIAM THOMAS, SHAJAHAN-HAQ, AYESHA N. · 2016 to 2020
$2.0M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA201092
6 · The paper itself

Abstract

Advocates bring unique and important viewpoints to the cancer research process, ensuring that scientific and medical advances are patient-centered and relevant. In this article, we discuss the benefits of engaging advocates in cancer research and underscore ways in which both the scientific and patient communities can facilitate this mutually beneficial collaboration. We discuss how to establish and nurture successful scientist-advocate relationships throughout the research process. We review opportunities that are available to advocates who want to obtain training in the evaluation of cancer research. We also suggest practical solutions that can strengthen communication between scientists and advocates, such as introducing scientist-advocate interactions at the trainee level. Finally, we highlight the essential role social media can play in disseminating patient-supported cancer research findings to the patient community and in raising awareness of the importance of promoting cancer research. Our perspective offers a model that Georgetown Breast Cancer Advocates have found effective and which could be one option for those interested in developing productive, successful, and sustainable collaborations between advocates and scientists in cancer research.

Indexed as

Models, OrganizationalPatient AdvocacyProfessional-Patient RelationsAcademies and InstitutesBreast NeoplasmsCooperative BehaviorFemaleHospitalsHumansInterdisciplinary CommunicationMedical OncologyOrganizations, NonprofitResearch DesignResearch PersonnelResearch Support as TopicUnited States

Identifiers

PMID30120210
PMCPMC6548189

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.